argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities - PressReach
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
After a pit stop on Friday, the Bel20 resumes its record-breaking race. This time with Argenx as the standout performer, thanks to a Californian peptide deal.
argenx buys macrocycle partner Unnatural Products for up to $1.15 billion - European Biotechnology Magazine
Dutch-Belgian immunology company argenx has agreed to acquire California-based Unnatural Products Inc. (UNP) for up to $1.15 billion (€1.03 billion), turning an existing drug-discovery partnership into full ownership of the macrocyclic peptide specialist.
argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities - PressReach
Pairs Unnatural Products’ (UNP) peptide expertise with argenx's antibody engineering, expanding the ways to target novel biology Extends argenx’s immunology innovation to more patients, with the potential for oral and long-acting medicines Builds on more than two years of collaboration and investment; UNP to continue operating from Santa Cruz, California with its current team, preserving … Continue reading "argenx to Acquire Unnatural Products, …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
